Prepaid Cards for Clinical Trial Participants
- ccerqueda
- 2 hours ago
- 9 min read
Prepaid Cards for Clinical Trial Participants
Paying research participants reliably is more than a final administrative step. Sponsors, CROs, and research organizations must align stipends, visit payments, and expense reimbursements with the trial protocol while giving participants a practical way to access approved funds.
Prepaid cards for clinical trial participants can provide a controlled disbursement method for approved stipends, visit payments, and eligible reimbursements. A well-designed programme can use virtual or physical cards, sponsor-defined funding rules, and documented workflows while supporting participant access across relevant markets.
The card is only one part of the solution. A dependable programme also needs clear eligibility rules, payment approvals, participant support, monitoring, reconciliation, and transparent terms.
How Prepaid Cards for Clinical Trial Participants Support Study Payments
Prepaid cards can connect an approved study event with a documented payment. After a participant completes a protocol-defined visit or submits an eligible expense, an authorized coordinator can trigger the appropriate disbursement. The sponsor retains control of the policy while the issuing programme provides the payment infrastructure.
When a study spans multiple sites, countries, or participant groups, payment administration can become a significant operating responsibility. Sponsors, CROs, and research organizations need a repeatable way to connect approved study activity with the right payment. Participants need clear information about when and how funds become available.
A prepaid card programme can reduce reliance on repeated cash handling or paper checks. It can support several payment categories within one operating model. These may include a stipend for participant time, a visit payment tied to a scheduled appointment, or reimbursement for an approved study-related expense. Each category should be documented in the sponsor's operating procedures so site teams apply the rules consistently.
Match the payment to the participant milestone
Payment schedules commonly align with the completion of study-related visits or other protocol-defined milestones. A coordinator can verify that the participant completed the relevant activity, confirm the amount authorized under the study budget, and initiate payment through the programme. This separates the clinical decision from the financial execution and creates a repeatable process across sites.
Keep a clear disbursement trail
Administration matters as much as delivery. The programme should define who can approve a payment, what participant or expense documentation is required, and how exceptions are handled. Virginia Commonwealth University describes documentation requirements for reimbursement and stipend distribution in its research prepaid card programme guidance. That principle is useful for any study team: retain enough evidence to connect an approved milestone or expense with the resulting disbursement.
Automated workflows can help teams monitor payment status and prepare for reconciliation. Intercash's prepaid card disbursement services provide broader context on issuing payments to multiple recipients.
What Should Sponsors Look For in a Participant Payment Programme?
Intercash recommends assessing a participant payment programme against access, governance, controls, support, reporting, and market coverage. The best fit is not simply the fastest disbursement method. It is a programme that supports participants while giving the sponsor a documented, manageable operating process.
A payment method should be judged against the study's actual population and operating model. A programme that works for a domestic study with recurring visits may need to be adapted for a decentralized or multinational trial. Before selecting a provider, evaluate the following areas.
Participant access and communication
Participants may differ in their access to smartphones, bank accounts, reliable internet, or physical mail. Consider whether a virtual card, physical card, or combination is appropriate. Explain activation, balance access, permitted use, replacement procedures, support channels, and payment timing in plain language. Participant-facing materials should also explain any applicable terms that could affect access to funds.
Funding controls and documentation
Define who can request, approve, and release a payment. Set rules for eligibility, payment limits, replacement cards, disputed transactions, unused balances, and failed payments. Connect each disbursement to the study record or approved expense so the sponsor can investigate exceptions without reconstructing the process manually.
Reporting, support, and governance
Operators need visibility into issued cards, successful payments, rejected transactions, outstanding balances, and support cases. They also need a clear escalation route when a participant cannot access funds. Research, privacy, compliance, and financial stakeholders should review the proposed approach. Where applicable, the Institutional Review Board should consider whether the payment method, timing, terms, and communications are consistent with participant welfare.
These requirements help sponsors compare providers on operational fit rather than on the card product alone. They also make it easier to explain responsibilities across the sponsor, CRO, site teams, issuing partner, and participant.
Why Compliance Matters When Paying Research Participants
Participant payments combine financial activity with a regulated research environment. The sponsor and its partners must define how identity, eligibility, payment approval, data protection, fraud prevention, and support will be handled. The exact obligations depend on the programme structure, participants, jurisdictions, and applicable study requirements, so the payment model should be reviewed by the appropriate professionals.
Build controls into programme design
A turnkey issuing partner can support KYC and KYB checks, AML monitoring, PCI DSS controls, and fraud monitoring. These controls can help identify the businesses and parties involved in funding or administering a programme, monitor activity that may require review, and protect payment-card data. They do not remove the sponsor's responsibility for study-specific governance, escalation paths, participant communications, or required reviews.
Intercash provides white-label card issuing infrastructure for businesses. Its role can include ready BINs, licensed issuing-bank relationships, access to Visa, Mastercard, and Discover networks, programme management, and cardholder-facing technology through CardPortal. The client remains the owner of the participant-facing programme and its operating policies.
Make participant terms clear
Before enrollment or payment, participants should receive clear information about the payment schedule, eligibility conditions, and how funds can be accessed. They should also receive support details and applicable terms. VCU's guidance illustrates why payment documentation and defined administration steps matter for research programmes, but each sponsor must confirm the requirements that apply to its own study.
Keeping responsibilities distinct creates a more defensible operating model. The issuing partner supplies infrastructure and controls. The sponsor sets the study policy and ensures the overall payment approach fits the protocol and the jurisdictions in which the trial operates.
How to Build a Prepaid Card Workflow for a Clinical Trial
Build the workflow around the protocol, then connect each approved visit or expense to a documented payment event. The five stages are defining the policy, configuring controls, issuing and funding cards, reconciling activity, and closing out participants. Intercash can provide the white-label issuing layer while the sponsor retains study-specific governance.
A reliable participant payment programme is designed around the trial protocol, not added after visits begin. Sponsors, CROs, and research organizations should define who approves payments, when a participant becomes eligible, which expenses qualify, and how exceptions are handled. The issuing partner can then turn those rules into a controlled card programme.
Define the payment policy and scope
Map each milestone to a payment event. Distinguish stipends from expense reimbursements and document the evidence required for approval. Decide whether participants will receive physical, virtual, or both card formats. Set rules for replacement cards, disputed transactions, unused balances, and participant communications.
Configure controls and onboarding
Establish user permissions, approval thresholds, funding limits, and an escalation route for failed or delayed payments. Participant onboarding should explain activation, access, permitted use, support, and applicable terms in plain language. Required identity and programme checks should be handled consistently before funds are made available.
Issue cards and fund approved events
Issue the selected card after the participant and payment event meet the programme rules. Funding can then be tied to completed visits or approved expenses rather than handled through ad hoc cash or cheque processes. VCU's programme describes paying registered participants after visits once the project is approved and the required administration is completed. The timing and requirements for another study must be determined independently.
Monitor transactions and reconcile the ledger
Track payment status, returned or failed transactions, card activity, outstanding balances, and support cases. Reconcile disbursements to the study record and investigate exceptions promptly. PrepaidGate can give programme operators a central back-office view for issuance management, balance monitoring, transaction history, reporting, and fraud monitoring.
Close out participants and the programme
Define what happens when a participant withdraws, finishes the protocol, replaces a card, or has an unused balance. Record the final status, resolve open support cases, and retain the documentation required by the sponsor's policies. A consistent closeout process prevents inactive cards and unresolved payments from becoming a later audit issue.
How Prepaid Cards for Clinical Trial Participants Compare With Other Methods
Cards are not automatically the right payment method for every participant or study. Bank transfers, checks, cash, and digital wallets may be suitable in some programmes. The choice depends on participant preferences, local availability, study rules, reconciliation needs, support capacity, and the sponsor's control environment.
A blended model may be appropriate when a trial includes different participant groups or markets. The sponsor should document why each method is offered, how participants receive support, and how payments are reconciled. A method that is convenient for the study team but difficult for participants can undermine the payment experience.
Where White-Label Card Issuing Fits in Trial Payments
For a sponsor or research organization, launching a participant payment card requires more than a card design. It requires an issuing model, programme governance, cardholder support, funding controls, and a way to operate across the markets relevant to the study. A white-label Card-Issuing-as-a-Service provider can supply that infrastructure while the client owns the participant-facing programme and payment policy.
Keep the participant experience aligned with the sponsor
White-label cards can be designed around the sponsor's programme identity rather than presented as a consumer product from the infrastructure provider. That can keep payment instructions, support pathways, and participant communications coherent. The business still needs to define the experience, eligibility, disbursement rules, and escalation process before launch.
Use issuing infrastructure instead of rebuilding the chain
Intercash is a BIN sponsor and programme manager with ready BINs, licensed issuing-bank relationships, and network access. Its turnkey model is intended to help businesses avoid the heavy setup and operational burden of building card infrastructure in-house. Available card options include plastic, virtual, gift, metallic, and debit cards, alongside global payout capabilities, subject to programme requirements and supported markets.
Intercash does not market directly to end cardholders or compete with the businesses using its infrastructure. It supports business-led programmes through PrepaidGate, the merchant back office, and CardPortal, the cardholder portal and app.
Connect the card programme to the wider payout strategy
A clinical trial may involve participants, sites, contractors, and other recipients with different payment needs. A sponsor can assess whether cards, transfers, or another method best fits each use case. Intercash's white-label card issuing infrastructure gives businesses a starting point for that conversation.
Before selecting a provider, document the study's markets, participant access requirements, payment categories, funding approvals, reconciliation process, support expectations, and compliance responsibilities. That preparation makes it easier to evaluate a programme on operational fit rather than on the card product alone.
Frequently Asked Questions
What are prepaid cards for clinical trial participants?
They are prepaid payment cards used by a sponsor, CRO, research organization, or programme manager to distribute approved participant payments. Depending on the programme design, a card may support visit stipends, reimbursements, or other protocol-defined disbursements. The sponsor sets the payment policy and should explain the terms and access process to participants.
How can prepaid cards be used for clinical trial stipends?
After a participant is enrolled and a payment is approved, the programme operator can fund the participant's card according to the study's payment schedule. A virtual or physical card may be appropriate depending on participant access, market, and programme requirements. Each payment should be supported by an operational record that helps the study team reconcile approved visits, reimbursements, and outstanding balances.
What should a sponsor consider before using prepaid cards?
Consider participant accessibility, funding and spending controls, documentation, support, reporting, data protection, and the governance process for the study. Payment terms should be transparent and fit the protocol and relevant review requirements. Sponsors should also confirm how the issuing partner handles identity checks, monitoring, fraud controls, and cardholder support.
Are prepaid cards the only way to pay clinical trial participants?
No. Bank transfers, checks, cash, and digital wallets may also be suitable in some programmes. The right choice depends on participant preferences, local availability, study rules, reconciliation needs, and the sponsor's control environment. A study can use more than one method when it spans different participant groups or markets.
Can a business create a white-label participant payment card programme?
Yes. A business can work with a Card-Issuing-as-a-Service provider to design a branded programme rather than building every issuing function in-house. The provider's role, supported markets, card options, controls, and compliance responsibilities should be confirmed during programme design. Intercash provides white-label issuing infrastructure for businesses and does not market directly to end cardholders.
Discuss Your Participant Payment Programme
A clinical trial payment programme should reflect the study design, participant needs, operating model, and markets involved. Intercash supports businesses that need white-label card issuing infrastructure for business-led disbursement programmes.
Share your requirements with the Intercash team to explore an appropriate issuing and payout model for your research organization or sponsor programme.
